Cellular mechanisms for developmental toxicity of chlorpyrifos: Targeting the adenylyl cyclase signaling cascade

Toxicology and Applied Pharmacology

Volumn 145, Issue 1, 1997, Pages 158-174

  Song, X ^a   Seidler, F J ^a   Saleh, J L ^a   Zhang, J ^a   Padilla, S ^b   Slotkin, T A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CHLORPYRIFOS; CHOLINESTERASE; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTRANSMITTER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; NEUROTOXICITY; NEWBORN; NONHUMAN; PARASYMPATHETIC INNERVATION; RAT;

ANIMALIA;

EID: 0031194056     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8171     Document Type: Article

References (68)

1. Bhat N. R., Shanker G., Pieringer R. A. Cell proliferation in growing cultures of dissociated embryonic mouse brain: Macromolecule and ornithine decarboxylase synthesis and regulation by hormones and drugs. J. Neurosci. Res. 10:1983;221-230.
2. 3. Brain Res. 475:1988;1-7.
3. Campbell C. G., Seidler F. J., Slotkin T. A. Chlorpyrifos interferes with cell development in rat brain regions. Brain Res. Bull. 1997.
4. Chakraborti T. K., Farrar J. D., Pope C. N. Comparative neurochemical and neurobehavioral effects of repeated chlorpyrifos exposures in young and adult rats. Pharmacol. Biochem. Behav. 46:1993;219-224.
5. Chambers J. E., Carr R. L. Inhibition patterns of brain acetylcholinesterase and hepatic and plasma aliesterases following exposures to three phosphorothionate insecticides and their oxons in rats. Fundam. Appl. Toxicol. 21:1993;111-119.
6. Chaudhry A., Granneman J. G. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am. J. Physiol. 261:1991;R403-R411.
7. Chaudhry A., Muffler L. A., Yao R. H., Granneman J. G. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue. Am. J. Physiol. 270:1996;R755-R760.
8. Chaudhuri J., Chakraborti T. K., Chanda S., Pope C. N. Differential modulation of organophosphate-sensitive muscarinic receptor subtypes in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8:1993;207-216.
9. Claycomb W. C. Biochemical aspects of cardiac muscle differentiation. J. Biol. Chem. 251:1976;6082-6089.
10. Cosenza M. E., Bidanet J. Effects of chlorpyrifos on neuronal development in rat embryo midbrain micromass cultures. Vet. Human Toxicol. 37:1995;118-121.
11. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Human Dev. 3:1979;79-83.
12. Duncan C. P., Seidler F. J., Lappi S. E., Slotkin T. A. Dual control of DNA synthesis by α- and β-adrenergic mechanisms in normoxic and hypoxic neonatal rat brain. Dev. Brain Res. 55:1990;29-33.
13. Ellman G. L., Courtney K. D., Anders V., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
14. Fenske R. A., Black K. G., Elkner K. P., Lee C., Methner M. M., Soto R. Potential exposure and health risks of infants following indoor residential pesticide applications. Am. J. Pub. Health. 80:1990;689-693.
15. Guidotti A. Adenosine 3′,5′-monophosphate concentrations and isoproterenol-induced synthesis of deoxyribonucleic acid in mouse parotid gland. Mol. Pharmacol. 8:1972;521-530.
16. Gupta R. C., Thornburg J. E., Stedman D. B., Welsch F. Effect of subchronic administration of methyl parathion onin vivo. Toxicol. Appl. Pharmacol. 72:1984;457-468.
17. Gurwitz D., Haring R., Heldman E., Fraser C. M., Manor D., Fisher A. Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands. Eur. J. Pharmacol. 267:1994;21-31.
18. 3. Int. J. Dev. Neurosci. 3:1985;567-571.
19. Hohmann C. F., Brooks A. R., Coyle J. T. Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development. Dev. Brain Res. 42:1988;253-264.
20. Hou Q.-C., Eylers J. P., Lappi S. E., Kavlock R. J., Slotkin T. A. Neonatal sympathectomy compromises development of responses of ornithine decarboxylase to hormonal stimulation in peripheral tissues. J. Dev. Physiol. 12:1989;189-192.
21. Huff R. A., Abou-Donia M. B. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. Neurotoxicology. 16:1995;281-290.
22. Huff R. A., Corcoran J. J., Anderson J. K., Abou-Donia M. B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 269:1994;329-335.
23. Huff R. A., Seidler F. J., Slotkin T. A. Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci. 48:1991;1059-1066.
24. Hultgårdh-Nilsson A., Querol-Ferrer V., Jonzon B., Krondahl U., Nilsson J. Cyclic AMP, early response gene expression, and DNA synthesis in rat smooth muscle cells. Exp. Cell Res. 214:1994;297-302.
25. Hunter D. L., Marshall R. S., Padilla S. Automated instrument analysis of cholinesterase activity in tissues from carbamate-treated animals: A cautionary note. Toxicol. Methods. 1997.
26. Kaplan J. G., Kessler J., Rosenberg N., Pack D. Sensory disturbances associated with Dursban (chlorpyrifos) exposure. Neurology. 43:1993;2193-2196.
27. 3. Fundam. Appl. Toxicol. 34:1996;84-90.
28. Lovell J. Effects of 6-hydroxydopamine-induced norepinephrine depletion on cerebellar development. Dev. Neurosci. 5:1982;359-368.
29. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-270.
30. Mangels L. A., Gnegy M. E. Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells. Mol. Brain Res. 12:1992;103-110.
31. McFarland B. J., Seidler F. J., Slotkin T. A. Inhibition of DNA synthesis in neonatal rat brain regions caused by acute nicotine administration. Dev. Brain Res. 58:1991;223-229.
32. McMillian M. K., Schanberg S. M., Kuhn C. M. Ontogeny of rat hepatic adrenoceptors. J. Pharmacol. Exp. Ther. 227:1983;181-186.
33. iαoα. J. Biol. Chem. 270:1995;16070-16074.
34. Mills E. Time course for development of vagal inhibition of the heart in neonatal rats. Life Sci. 23:1978;2717-2720.
35. Navarro H. A., Kudlacz E. M., Slotkin T. A. Control of adenylate cyclase activity in developing rat heart and liver: Effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
36. Navarro H. A., Seidler F. J., Eylers J. P., Baker F. E., Dobbins S. S., Lappi S. E., Slotkin T. A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
37. Nolan R. J., Rick D. L., Freshour N. L., Saunders J. H. Chlorpyrifos: Pharmacokinetics in human volunteers. Toxicol. Appl. Pharmacol. 73:1984;8-15.
38. 2+. J. Neurochem. 63:1994;161-168.
39. Pope C. N., Chakraborti T. K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology. 73:1992;35-43.
40. Pope C. N., Chakraborti T. K., Chapman M. L., Farrar J. D. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol. Biochem. Behav. 42:1992;251-256.
41. Pope C. N., Chakraborti T. K., Chapman M. L., Farrar J. D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 68:1991;51-61.
42. Reinis S., Goldman J. M. The Development of the Brain: Biological and Functional Perspectives. 1980;Charles C. Thomas, Springfield.
43. Reithmann C., Werdan K. Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein α-subunits. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;27-34.
44. Richardson R. J., Moore T. B., Kayyali U. S., Randall J. C. Chlorpyrifos: Assessment of potential for delayed neurotoxicity by repeated dosing in adult hens with monitoring of brain acetylcholinesterase, brain and lymphocyte neurotoxic esterase and plasma butyrylcholinesterase activities. Fundam. Appl. Toxicol. 21:1993;89-96.
45. Rocha E. S., Swanson K. L., Aracava Y., Goolsby J. E., Maelicke A., Albuquerque E. X. Paraoxon: Cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 278:1996;1175-1187.
46. Rodier P. M. Structural-functional relationships in experimentally induced brain damage. Prog. Brain Res. 73:1988;335-348.
47. Rodier P. M. Developing brain as a target of toxicity. Environ. Health Perspect. 103:1995;73-76.
48. Sánchez-Capelo A., Peñafiel R., Tovar A., Galindo J. D., Cremades A. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: Influence of testosterone. Biol. Neonate. 66:1994;119-127.
49. Scarpace P. J., Matheny M., Tumer N. Myocardial adenylyl cyclase type V and VI mRNA: Differential regulation with age. J. Cardiovasc. Pharmacol. 27:1996;86-90.
50. Seamon K., Daly J. W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J. Biol. Chem. 256:1981;9799-9801.
51. Seamon K. B., Daly J. W. Forskolin: Its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20:1986;1-150.
52. Seidler F. J., Slotkin T. A. Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Brit. J. Pharmacol. 65:1979;431-434.
53. Slotkin T. A. Endocrine control of synaptic development in the sympathetic nervous system: The cardiac-sympathetic axis. Developmental Neurobiology of the Autonomic Nervous System. 1986;Humana Press, Clifton. p. 97-133.
54. Slotkin T. A., Kavlock R. J., Cowdery T., Orband L., Bartolome M., Whitmore W. L., Bartolome J. Effects of neonatal methylmercury exposure on adrenergic receptor binding sites in peripheral tissues of the developing rat. Toxicology. 41:1986;95-106.
55. Slotkin T. A., Lau C., Lappi S. E., Seidler F. J. Can intracellular signaling pathways predict developmental abnormalities? Sensitivity of the adenylyl cyclase/c-fos. Biomarkers. 1:1996;115-122.
56. Slotkin T. A., Lau C., McCook E. C., Lappi S. E., Seidler F. J. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: A mechanism for heterologous teratogenic sensitization? Toxicol. Appl. Pharmacol. 127:1994;64-75.
57. Slotkin T. A., McCook E. C., Seidler F. J. Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos. Brain Res. 750:1997;180-188.
58. Slotkin T. A., Navarro H. A., McCook E. C., Seidler F. J. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci. 47:1990;1561-1567.
59. 3via. J. Pharmacol. Exp. Ther. 242:1987a;232-237.
60. Slotkin T. A., Whitmore W. L., Orband-Miller L., Queen K. L., Haim K. Beta. J. Pharmacol. Exp. Ther. 243:1987b;101-109.
61. Slotkin T. A., Windh R., Whitmore W. L., Seidler F. J. Adrenergic control of DNA synthesis in developing rat brain regions: Effects of intracisternal administration of isoproterenol. Brain Res. Bull. 21:1988;737-740.
62. Snedecor G. W., Cochran W. G. Statistical Methods. 1967;Iowa State University Press, Ames.
63. Thomas J. M., Hoffman B. B. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol. Pharmacol. 49:1996;907-914.
64. Van Wijk R., Wicks W. D., Bevers M. M., Van Rijn J. Rapid arrest of DNA synthesis by N6,O2′-dibutyryl cyclic adenosine 3′,5′-monophosphate in cultured hepatoma cells. Cancer Res. 33:1973;1331-1338.
65. Vernadakis A., Gibson D. A. Role of neurotransmitter substances in neural growth. Dancis J., Hwang J. C. Perinatal Pharmacology: Problems and Priorities. 1974;65-76 Raven Press, New York.
66. Ward T. R., Mundy W. R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res. Bull. 39:1996;49-55.
67. Whitney K. D., Seidler F. J., Slotkin T. A. Developmental neurotoxicity of chlorpyrifos: Cellular mechanisms. Toxicol. Appl. Pharmacol. 134:1995;53-62.
68. 1. Neurotoxicol. Teratol. 15:1993;107-115.